| |
| |
|
| Insider
Information: |
Tanner Deborah L |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
29,340 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,569,160 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,340 |
|
|
| Total
Value |
$7,569,160 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Covance Inc |
CVD |
Corp. Executive Vice P... |
2015-02-19 |
0 |
2010-06-22 |
0 |
Premium* |
|
|
Laboratory Corp of America |
LH |
CEO, Covance Drug Deve... |
2016-03-11 |
19,754 |
|
0 |
Premium* |
|
|
West Pharmaceutical Services Inc |
WST |
Director |
2024-04-23 |
9,586 |
2017-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2010-06-22 |
4 |
D |
$54.37 |
$51,978 |
I/I |
(956) |
0 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2015-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,488) |
0 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice PresidentOf |
• – – |
2006-02-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
327 |
|
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,483 |
1,483 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2018-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,824 |
3,309 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2019-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
4,881 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice PresidentOf |
• – – |
2006-02-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,364 |
|
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2020-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
975 |
7,180 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2021-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
577 |
7,774 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
632 |
8,406 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2023-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
616 |
9,022 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Director |
• • – |
2024-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
564 |
9,586 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug DevelopmentO |
• – – |
2016-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,412 |
|
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2007-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
8,020 |
13,756 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2007-09-11 |
4 |
S |
$75.29 |
$226,017 |
D/D |
(3,000) |
14,186 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2008-12-19 |
4 |
D |
$41.00 |
$142,393 |
D/D |
(3,473) |
15,642 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2010-02-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,043) |
16,948 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2007-09-11 |
4 |
OE |
$22.95 |
$68,850 |
D/D |
3,000 |
17,186 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2008-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,672 |
18,979 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2009-12-18 |
4 |
D |
$51.18 |
$116,281 |
D/D |
(2,272) |
18,991 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2008-08-28 |
4 |
S |
$95.00 |
$361,380 |
D/D |
(3,804) |
19,115 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2016-03-11 |
4 |
D |
$115.49 |
$529,753 |
D/D |
(4,587) |
19,754 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2010-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,249 |
21,197 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2009-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(480) |
21,263 |
0 |
- |
|
| CVD |
Covance Inc |
Corporate Sr. Vice President |
• – – |
2009-02-19 |
4 |
D |
$39.80 |
$12,577 |
D/D |
(316) |
21,743 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
